Fore Kopi Indonesia Tbk. vs Brigit Biofarmaka Teknologi Tbk. — how do they compare? Fore Kopi Indonesia Tbk. trades at Rp615 (market cap 5.44T, 1.89M 24h volume), while Brigit Biofarmaka Teknologi Tbk. trades at Rp246 (market cap 167.37B, 71K 24h volume). The key difference: Fore Kopi Indonesia Tbk. is far larger — about 32.5× Brigit Biofarmaka Teknologi Tbk.'s market cap, and Fore Kopi Indonesia Tbk. is more actively traded (1.89M versus 71K). Which is the better fit depends on your goals.
| FORE | OBAT | |
|---|---|---|
Market Cap | 5.44T | 167.37B |
Volume | 1.89M | 71K |
Lot | 18.9K | 710 |
Turnover | 1.15B | 17.51M |
Average Price | 609.92 | 246.63 |
Value | 1.15B | 17.51M |
Indicative Equilibrium Price | 615 | 246 |
Indicative Equilibrium Volume | 1.29K | 1 |
Trailing returns across standard periods
Latest headlines on both assets
PT Fore Kopi Indonesia Tbk (the Company) was established in Jakarta based on Notarial Deed No. 6 dated July 3, 2018 of Jose Dima Satria, S.H., M.Kn. The Company commenced its commercial operations in August 2018. The controlling shareholder of the Company is EVLab Fore Pte. Ltd., through its ownership in Fore Holdings Pte. Ltd.
Read more on FORE →PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Read more on OBAT →